Literature DB >> 19604656

Brucellosis: a re-emerging zoonosis.

Mohamed N Seleem1, Stephen M Boyle, Nammalwar Sriranganathan.   

Abstract

Brucellosis, especially caused by Brucella melitensis, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually. The bacterial pathogen is classified by the CDC as a category (B) pathogen that has potential for development as a bio-weapon. Brucella spp. are considered as the most common laboratory-acquired pathogens. The geographical distribution of brucellosis is constantly changing with new foci emerging or re-emerging. The disease occurs worldwide in both animals and humans, except in those countries where bovine brucellosis has been eradicated. The worldwide economic losses due to brucellosis are extensive not only in animal production but also in human health. Although a number of successful vaccines are being used for immunization of animals, no satisfactory vaccine against human brucellosis is available. When the incidence of brucellosis is controlled in the animal reservoirs, there is a corresponding and significant decline in the incidence in humans. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604656     DOI: 10.1016/j.vetmic.2009.06.021

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  194 in total

1.  Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; Y Fan; M M Kahl-McDonagh; T A Ficht
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Biochemical Characterization of WbkC, an N-Formyltransferase from Brucella melitensis.

Authors:  Alexander S Riegert; Daniel P Chantigian; James B Thoden; Peter A Tipton; Hazel M Holden
Journal:  Biochemistry       Date:  2017-07-05       Impact factor: 3.162

3.  Small ruminant brucellosis and community perception in Jijiga District, Somali Regional State, Eastern Ethiopia.

Authors:  Mihreteab Bekele; Hassen Mohammed; Mulugeta Tefera; Tadele Tolosa
Journal:  Trop Anim Health Prod       Date:  2011-01-12       Impact factor: 1.559

4.  A LysR-family transcriptional regulator required for virulence in Brucella abortus is highly conserved among the α-proteobacteria.

Authors:  Lauren M Sheehan; James A Budnick; Catlyn Blanchard; Paul M Dunman; Clayton C Caswell
Journal:  Mol Microbiol       Date:  2015-08-14       Impact factor: 3.501

5.  Brucella placentitis and seroprevalence in northern fur seals ( Callorhinus ursinus) of the Pribilof Islands, Alaska.

Authors:  Colleen G Duncan; Rebekah Tiller; Demetrius Mathis; Robyn Stoddard; Gilbert J Kersh; Bobette Dickerson; Tom Gelatt
Journal:  J Vet Diagn Invest       Date:  2014-07       Impact factor: 1.279

6.  Bovine and Caprine Brucellosis in Bangladesh: Bayesian evaluation of four serological tests, true prevalence, and associated risk factors in household animals.

Authors:  Md Shamim Ahasan; Md Siddiqur Rahman; A K M Anisur Rahman; Dirk Berkvens
Journal:  Trop Anim Health Prod       Date:  2016-09-15       Impact factor: 1.559

7.  Brucellosis in Occupationally Exposed Groups.

Authors:  Smita S Mangalgi; Annapurna G Sajjan; Shivajirao T Mohite; Shivali Gajul
Journal:  J Clin Diagn Res       Date:  2016-04-01

8.  Epidemiological Modeling of Bovine Brucellosis in India.

Authors:  Gloria J Kang; L Gunaseelan; Kaja M Abbas
Journal:  Proc IEEE Int Conf Big Data       Date:  2014-10

9.  Ovine and Caprine Brucellosis (Brucella melitensis) in Aborted Animals in Jordanian Sheep and Goat Flocks.

Authors:  Assadullah Samadi; M Mk Ababneh; N D Giadinis; S Q Lafi
Journal:  Vet Med Int       Date:  2010-10-28

10.  Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.

Authors:  Fangkun Wang; Zujian Qiao; Sen Hu; Wenxing Liu; Huajun Zheng; Sidang Liu; Xiaomin Zhao; Zhigao Bu
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.